Načítá se...
High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma
BACKGROUND: Current clinical risk factors stratify patients with neuroblastoma (NB) for appropriate treatments, yet patients with similar clinical behaviors evoke variable responses. MYCN amplification is one of the established drivers of NB and, when combined with high-risk displays, worsens outcom...
Uloženo v:
| Vydáno v: | JNCI Cancer Spectr |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649748/ https://ncbi.nlm.nih.gov/pubmed/31360848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pky015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|